{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:14:37Z","timestamp":1759011277938},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Determination of the major serogroups is an important step for establishing a vaccine programme and management strategy targeting<jats:italic>Neisseria meningitidis<\/jats:italic>. From April 2010 to November 2016, a total of 25\u2009<jats:italic>N. meningitidis<\/jats:italic>isolates were collected in South Korea, in collaboration with the Korean Society of Clinical Microbiology. Among isolates, 19 isolates were recovered from blood and\/or cerebrospinal fluid (CSF) in 46 patients who suffered from invasive meningococcal disease (IMD), and six isolates were found in sputum or the throat. The most common serogroup was serogroup B (overall, 36%, n\u2009=\u20099\/25; IMD, 37%, n\u2009=\u20097\/19), which was isolated in every year of the research period except for 2011. There were five serogroup W isolates recovered from patients in military service. W was no longer isolated after initiation of a vaccine programme for military trainees, but serogroup B caused meningitis in an army recruit training centre in 2015. In MLST analysis, 14 sequence types were found, and all isolates belonging to W showed the same molecular epidemiologic characteristics (W:P1.5-1, 2-2:F3-9:ST-8912). All isolates showed susceptibility to ceftriaxone, meropenem, ciprofloxacin, minocycline, and rifampin; however, the susceptibility rates to penicillin and ampicillin for isolates with W and C capsules were 22% and 30%, respectively.<\/jats:p>","DOI":"10.1038\/s41598-018-23365-8","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T01:30:37Z","timestamp":1522287037000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010\u20132016"],"prefix":"10.1038","volume":"8","author":[{"given":"Hyukmin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younghee","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Won","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"23365_CR1","doi-asserted-by":"crossref","unstructured":"Elias, J., Frosch, M. & Vogel, U. Neisseria. in Manual of clinical microbiology (Jorgensen, J. H. & Pfaller, M. A.). 635\u201351 (ASM Press, 2015).","DOI":"10.1128\/9781555817381.ch34"},{"key":"23365_CR2","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/cid\/civ028","volume":"60","author":"M Sadarangani","year":"2015","unstructured":"Sadarangani, M. et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin. Infect. Dis. 60, e27\u201335 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"23365_CR3","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections ProgramNetwork, Neisseria meningitidis, 2015. http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening15.pdf (2015)."},{"key":"23365_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"GBD 2013 DALYs and HALE Collaborators","year":"2015","unstructured":"GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition. Lancet. 386, 2145\u20132191 (2015).","journal-title":"Lancet."},{"key":"23365_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","volume":"13","author":"M van Deuren","year":"2000","unstructured":"van Deuren, M., Brandtzaeg, P. & van der Meer, J. W. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13, 144\u2013166 (2000).","journal-title":"Clin. Microbiol. Rev."},{"key":"23365_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3201\/eid1904.111799","volume":"19","author":"OB Harrison","year":"2013","unstructured":"Harrison, O. B. et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg. Infect. Dis. 19, 566\u2013573 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"23365_CR7","doi-asserted-by":"publisher","first-page":"31529","DOI":"10.1074\/jbc.M304607200","volume":"278","author":"A Antignac","year":"2003","unstructured":"Antignac, A. et al. Correlation between alterations of the Penicillin-Binding Protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J. Biol. Chem. 278, 31529\u201331535 (2003).","journal-title":"J. Biol. Chem."},{"key":"23365_CR8","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 \u2013 Invasive meningococcal disease. http:\/\/ecdc.europa.eu\/en\/healthtopics\/meningococcaldisease\/Pages\/Annualepidemiologicalreport2016.aspx (2016)."},{"key":"23365_CR9","unstructured":"Korean Centers Disease Control and Prevention. Infectious Diseases Surveillance Yearbook, 2016. Osong;Somun Press. 2017 (In Korean) [cited 2017 June 13] Available from: http:\/\/www.cdc.go.kr\/CDC\/cms\/cmsFileDownload.jsp?fid=32&cid=75290&fieldName=attach1&index=1."},{"key":"23365_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1469-0691.2005.01327.x","volume":"12","author":"E Bronska","year":"2006","unstructured":"Bronska, E. et al. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin. Microbiol. Infect. 12, 137\u2013141 (2006).","journal-title":"Clin. Microbiol. Infect."},{"key":"23365_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jinf.2013.06.007","volume":"67","author":"E Heinsbroek","year":"2013","unstructured":"Heinsbroek, E. et al. Added value of PCR-testing for confirmation of invasive meningococcal disease in England. J. Infect. 67, 385\u2013390 (2013).","journal-title":"J. Infect."},{"key":"23365_CR12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7883\/yoken.JJID.2008.434","volume":"61","author":"SM Bae","year":"2008","unstructured":"Bae, S. M. & Kang, Y. H. Serological and genetic characterization of meningococcal isolates in Korea. Jpn. J. Infect. Dis. 61, 434\u2013437 (2008).","journal-title":"Jpn. J. Infect. Dis."},{"key":"23365_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1471-2334-12-310","volume":"12","author":"SA Kim","year":"2012","unstructured":"Kim, S. A. et al. An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia. BMC Infect. Dis. 12, 310\u201318 (2012).","journal-title":"BMC Infect. Dis."},{"key":"23365_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3947\/ic.2016.48.1.51","volume":"48","author":"JY Heo","year":"2016","unstructured":"Heo, J. Y. Meningococcal Disease in Korea: an Epidemiologic Study of the Underestimated Infectious Disease. Infect. Chemother. 48, 51\u20133 (2016).","journal-title":"Infect. Chemother."},{"key":"23365_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3947\/ic.2016.48.1.12","volume":"48","author":"JH Kang","year":"2016","unstructured":"Kang, J. H. et al. A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea. Infect. Chemother. 48, 12\u20139 (2016).","journal-title":"Infect. Chemother."},{"key":"23365_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/archdischild-2015-308928","volume":"101","author":"SN Ladhani","year":"2016","unstructured":"Ladhani, S. N. et al. Enter B and W: two new meningococcal vaccine programmes launched. Arch. Dis. Child. 101, 91\u201395 (2016).","journal-title":"Arch. Dis. Child."},{"key":"23365_CR17","first-page":"E133","volume":"56","author":"R Gasparini","year":"2015","unstructured":"Gasparini, R., Amicizia, D., Lai, P. L. & Panatto, D. Meningococcal B vaccination strategies and their practical application in Italy. J. Prev. Med. Hyg. 56, E133\u2013E139 (2015).","journal-title":"J. Prev. Med. Hyg."},{"key":"23365_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.vaccine.2015.11.057","volume":"34","author":"PS Watson","year":"2016","unstructured":"Watson, P. S. & Turner, D. P. Clinical experience with the meningococcal B vaccine, Bexsero(\u00ae): Prospects for reducing the burden of meningococcal serogroup B disease. Vaccine. 34, 875\u2013880 (2016).","journal-title":"Vaccine."},{"key":"23365_CR19","first-page":"E116","volume":"56","author":"G Gabutti","year":"2015","unstructured":"Gabutti, G., Stefanati, A. & Kuhdari, P. Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J. Prev. Med. Hyg. 56, E116\u2013E120 (2015).","journal-title":"J. Prev. Med. Hyg."},{"key":"23365_CR20","first-page":"499","volume":"77","author":"G Campagne","year":"1999","unstructured":"Campagne, G. et al. Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396. Bull. World. Health. Organ. 77, 499\u2013508 (1999).","journal-title":"Bull. World. Health. Organ."},{"key":"23365_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3201\/eid2210.160468","volume":"22","author":"CB Kretz","year":"2016","unstructured":"Kretz, C. B. et al. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015. Emerg. Infect. Dis. 22, 1762\u20131768 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"23365_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3201\/eid2204.150653","volume":"22","author":"A Agnememel","year":"2016","unstructured":"Agnememel, A. et al. Neisseria meningitidis Serogroup X in Sub-Saharan Africa. Emerg. Infect. Dis. 22, 698\u2013702 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"23365_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1471-2334-12-310","volume":"12","author":"SA Kim","year":"2012","unstructured":"Kim, S. A. et al. An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia. BMC Infect. Dis. 12, 310\u2013318 (2012).","journal-title":"BMC Infect. Dis."},{"key":"23365_CR24","doi-asserted-by":"publisher","first-page":"e58065","DOI":"10.1371\/journal.pone.0058065","volume":"8","author":"C Sorhouet-Pereira","year":"2013","unstructured":"Sorhouet-Pereira, C. et al. Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010. PLoS One. 8, e58065 (2013).","journal-title":"PLoS One."},{"key":"23365_CR25","doi-asserted-by":"publisher","first-page":"e50659","DOI":"10.1371\/journal.pone.0050659","volume":"7","author":"R Gilca","year":"2012","unstructured":"Gilca, R. et al. The changing epidemiology of meningococcal disease in Quebec, Canada, 1991\u20132011: potential implications of emergence of new strains. PLoS One 7, e50659 (2012).","journal-title":"PLoS One"},{"key":"23365_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1542\/peds.2014-4015","volume":"135","author":"LA McNamara","year":"2015","unstructured":"McNamara, L. A. et al. First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak. Pediatrics. 135, 798\u2013804 (2015).","journal-title":"Pediatrics."},{"key":"23365_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3349\/ymj.2012.53.4.742","volume":"53","author":"A Durey","year":"2012","unstructured":"Durey, A. et al. Carriage rates and serogroups of Neisseria meningitidis among freshmen in a University dormitory in Korea. Yonsei Med. J. 53, 742\u2013747 (2012).","journal-title":"Yonsei Med. J."},{"key":"23365_CR28","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","volume":"35","author":"R Whittaker","year":"2017","unstructured":"Whittaker, R. et al. The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004-2014. Vaccine. 35, 2034\u20132041 (2017).","journal-title":"Vaccine."},{"key":"23365_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","volume":"31","author":"CL Trotter","year":"2007","unstructured":"Trotter, C. L. & Ramsay, M. E. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol. Rev. 31, 101\u2013107 (2007).","journal-title":"FEMS Microbiol. Rev."},{"key":"23365_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3346\/jkms.2017.32.7.1111","volume":"32","author":"HW Kim","year":"2017","unstructured":"Kim, H. W. et al. Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015. J. Korean Med. Sci. 32, 1111\u20131117 (2017).","journal-title":"J. Korean Med. Sci."},{"key":"23365_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3346\/jkms.2015.30.4.353","volume":"30","author":"JY Heo","year":"2015","unstructured":"Heo, J. Y. et al. Vaccination policy in Korean armed forces: current status and future challenge. J. Korean Med. Sci. 30, 353\u2013359 (2015).","journal-title":"J. Korean Med. Sci."},{"key":"23365_CR32","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1128\/AAC.00412-07","volume":"51","author":"MK Taha","year":"2007","unstructured":"Taha, M. K. et al. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 51, 2784\u20132792 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"23365_CR33","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/AAC.00353-06","volume":"50","author":"S Thulin","year":"2006","unstructured":"Thulin, S., Olcen, P., Fredlund, H. & Unemo, M. Total variation in the penA gene of Neisseria meningitidis: Correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob. Agents Chemother. 50, 3317\u20133324 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"23365_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3343\/alm.2016.36.3.275","volume":"36","author":"JY Ahn","year":"2016","unstructured":"Ahn, J. Y. et al. Septicemia Caused by Neisseria meningitidis With Decreased Ciprofloxacin Susceptibility: The First Case Report in Korea. Ann. Lab. Med. 36, 275\u2013277 (2016).","journal-title":"Ann. Lab. Med."},{"key":"23365_CR35","unstructured":"Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline MM18-A (CLSI, 2008)."},{"key":"23365_CR36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JCM.38.2.855-857.2000","volume":"38","author":"MK Taha","year":"2000","unstructured":"Taha, M. K. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J. Clin. Microbiol. 38, 855\u2013857 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"23365_CR37","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/JCM.44.3.1127-1131.2006","volume":"44","author":"DE Bennett","year":"2006","unstructured":"Bennett, D. E. & Cafferkey, M. T. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitides serogroups associated with invasive disease. J. Clin. Microbiol. 44, 1127\u20131131 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"23365_CR38","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing M100-S26 (CLSI, 2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23365-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T20:54:00Z","timestamp":1693601640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23365"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23365-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"12 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5292"}}